Galmed Pharmaceuticals Balance Sheet (2013-2026)

Reported Financials

Galmed Pharmaceuticals Quarterly Balance Sheet

Periods 53 quarters

Latest Jun 2026

Galmed Pharmaceuticals reported total assets of $18.28M and total liabilities of $5.54M for the quarter ended Jun 2026, down 20.3% year over year. This balance sheet covers 53 quarters of results from Mar 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Accumulated Depreciation		0.96M				0.99M				1.02M				1.10M
Loans - NetNet Loans						1.50M
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	7.06M	7.06M	3.74M	3.00M	4.06M	3.00M	2.13M	2.13M	2.13M	2.98M	2.98M	2.98M	9.72M	0.57M	4.77M	4.96M	3.31M	3.98M	1.60M	2.88M
Receivables - NetNet Receivables		1.12M				0.82M				0.48M				0.02M				0.05M
Receivables - OtherOther Receivables	1.67M	1.12M	0.84M	0.61M	1.15M	0.03M	0.06M	0.34M	0.77M	0.12M	0.25M	0.14M	0.43M	0.13M	0.45M	0.43M	0.55M	0.35M	0.45M	0.32M
Receivables		2.25M				0.86M				0.60M				0.15M				0.40M
Prepaid Assets														0.46M				0.27M
Current Assets	43.69M	36.05M	29.70M	23.13M	20.48M	14.72M	1.19M	9.79M	14.20M	13.24M	11.18M	10.08M	17.68M	0.61M	16.30M	21.08M	19.72M	18.63M	16.03M	11.71M
Non-Current Assets
Property, Plant & Equipment (Net)	0.15M	0.14M	0.14M	0.13M	0.12M	0.11M	0.01M	0.10M	0.09M	0.08M	0.07M			0.07M				0.06M		0.05M
Long-Term Investments						-1.50M		3.27M	3.27M	3.27M	3.27M	3.27M	3.27M	0.03M	2.12M	1.59M	1.59M	0.03M		4.64M
Goodwill																				1.76M
Goodwill & Intangibles																				1.76M
Other Non-Current Assets	0.11M	0.11M	0.11M	0.11M	0.11M	0.11M	0.11M	0.12M	0.12M	0.12M	0.12M	0.12M	0.12M	0.02M	0.27M	0.27M	0.27M	0.12M	0.12M	0.16M
Non-Current Assets	0.61M	0.55M	0.50M	0.45M	0.39M	1.84M	1.96M	3.49M	3.44M	3.39M	3.34M	3.27M	3.27M	0.24M	2.39M	1.86M	1.86M	0.26M		6.57M
Assets	44.30M	36.60M	30.20M	23.57M	20.87M	16.56M	1.19M	13.28M	17.64M	16.63M	14.52M	13.34M	20.95M	0.86M	18.68M	22.94M	21.58M	18.63M	16.03M	18.28M
Liabilities
Current Liabilities
Accounts Payables	5.23M	4.87M	4.83M	2.09M	4.75M	2.56M	0.11M	2.14M	1.47M	1.88M	1.38M	1.20M	1.34M	0.02M	1.31M	1.37M	1.67M	2.00M	1.72M	1.90M
Payables	5.23M	4.87M	4.83M	2.09M	4.75M	2.56M	0.11M	2.14M	1.47M	1.88M	1.38M	1.20M	1.34M	0.02M	1.31M	1.37M	1.67M	2.00M	1.72M	1.90M
Other Accumulated Expenses			-0.05M			0.64M	0.61M			0.60M				0.15M				0.16M
Short term Debt	1.11M	1.01M	0.81M	0.64M	0.28M	0.53M	0.54M	0.58M	0.62M	0.87M	0.38M	0.35M	1.17M	0.46M	0.50M	1.05M	0.80M	0.84M	0.35M	0.83M
Current Taxes														0.32M
Current Deferred Revenue
Total Current Liabilities	6.35M	5.88M	5.65M	2.73M	5.03M	3.09M	0.18M	2.72M	2.09M	2.75M	1.76M	1.55M	2.51M	4.33M	1.81M	2.42M	2.47M	2.85M	2.08M	2.81M
Non-Current Liabilities
Capital Leases
Non-Current Debt
Convertible Debt						4.09M	4.45M							3.85M				3.73M
Non-Current Deffered Revenue
Operating Leases	0.27M	0.23M	0.18M	0.13M	0.09M	0.04M								0.03M				0.08M		0.05M
Non-Current Deferred Tax Liability																				1.07M
Other Non-Current Liabilities																				1.62M
Total Non-Current Liabilities	0.27M	0.23M	0.18M	0.13M	0.09M	0.04M	5.06M			0.63M				1.67M						2.73M
Total Liabilities	6.62M	67.10M	5.83M	2.86M	5.12M	3.14M	-10.80M	2.72M	2.18M	2.75M	1.76M	1.55M	2.51M	-15.47M	1.81M	2.42M	2.47M	2.85M	2.08M	5.54M
Shareholder's Equity
Total Debt	1.11M	1.01M	0.81M	0.64M	0.28M	0.53M	0.54M	0.58M	0.62M	0.87M	0.38M	0.35M	1.17M	0.46M	0.50M	1.05M	0.80M	0.84M	0.35M	0.83M
Common Equity	37.68M	-30.50M	24.37M	20.71M	15.75M	13.42M	11.99M	10.55M	15.46M	13.88M	12.76M	11.79M	18.44M	16.33M	16.88M	20.52M	19.11M	15.78M	13.95M	12.74M
Liabilities and Shareholders Equity	44.30M	36.60M	30.20M	23.57M	20.87M	16.56M	1.19M	13.28M	17.64M	16.63M	14.52M	13.34M	20.95M	0.86M	18.68M	22.94M	21.58M	18.63M	16.03M	18.28M
Retained Earnings	-160.72M	-168.17M	-174.32M	-178.05M	-183.40M	-186.04M	-4.06M	-189.46M	-190.94M	-192.95M	-194.23M	-195.35M	-197.26M	-16.84M	-201.57M	-204.07M	-205.96M	-210.78M	-212.69M	-215.41M
Preferred Shares

Galmed Pharmaceuticals Balance Sheet API

Pull Galmed Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=EOCN&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "EOCN", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=EOCN&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Galmed Pharmaceuticals EOCN Balance Sheet (2013-2026)

Galmed Pharmaceuticals Quarterly Balance Sheet

Galmed Pharmaceuticals Balance Sheet API

Create an account

Sign In

Reset Password